Document is current
Any future updates will be listed below
-
Authors
Seifert, Robert http://orcid.org/0000-0001-5985-7701
Kersting, David
Rischpler, Christoph
Sandach, Patrick
Ferdinandus, Justin
Fendler, Wolfgang P.
Rahbar, Kambiz
Weckesser, Matthias
Umutlu, Lale
Hanoun, Christine
Hüttmann, Andreas http://orcid.org/0000-0003-2230-3873
Reinhardt, Hans Christian
von Tresckow, Bastian http://orcid.org/0000-0003-1410-4487
Herrmann, Ken http://orcid.org/0000-0002-9662-7259
Dührsen, Ulrich http://orcid.org/0000-0002-4034-9472
Schäfers, Michael
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (107592, 110515)
- License Information
-
More Information
Article History
Received: 20 June 2022
Revised: 13 August 2022
Accepted: 16 September 2022
First Online: 14 October 2022
Conflict of interest
: DK received a research grant from Pfizer outside of the submitted work. CR recieved a research grant from Pfizer, reports consultancy for Pfizer and Adacap, and speaker honoraria from Adacap, Alnylam, BTG, GE Healthcare, Pfizer, and Siemens Healthineers, all outside the submitted work. HCR received consulting and lecture fees from Abbvie, AstraZeneca, Vertex, Roche, and Merck. HCR received research funding from Gilead Pharmaceuticals and AstraZeneca. HCR is a co-founder of CDL Therapeutics GmbH. KH received personal fees from BTG, Bayer, Sofie Biosciences, SIRTEX, Adacap, Curium, Endocyte, IPSEN, Siemens Healthineers, GE Healthcare, Amgen, Novartis, ymabs, Aktis, Oncology, Pharma15 as well as non-financial support from ABX and grants from BTG. UD chairs data and safety monitoring boards of studies performed by Amgen and CPT Cellex Patient Treatment. WPF reports fees from SOFIE Bioscience (research funding), Janssen (consultant, speakers bureau), Calyx (consultant), Bayer (consultant, speakers bureau), and Parexel (image review) outside of the submitted work. RS has received research support from the Else Kröner-Fresenius-Stiftung and Boehringer Ingelheim Fonds. The University Hospital Münster, Department of Nuclear Medicine received a research grant from Siemens Healthineers, which supported the execution of the study. All other authors declare no conflict of interest with respect to this manuscript.
